Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Indukern Internacional appears to refer to the Indukern group operating under Grupo Indukern, a Spain-based family-owned healthcare group active in human and animal health. The group states that it operates with a "one health" focus and highlights its main companies including Kern Pharma and Calier. Based on available public information, this is primarily a commercial healthcare organization rather than a clinical-stage biotech developer, with activities centered on marketed products, distribution, and operating subsidiaries across multiple countries. Publicly accessible sources do not show a discrete innovative drug pipeline for Indukern Internacional itself, suggesting it functions mainly as a parent or operating company within the broader Grupo Indukern structure. The company has an international footprint and sells products in more than 80 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Indukern Internacional.